Differing deregulation of HER2 in primary gastric cancer and synchronous related metastatic lymph nodes

BACKGROUND: The aim of this study was to investigate how differences in expression of HER2 between primary gastric cancers (PGCs) and their corresponding metastatic lymph nodes (LMNs) might affect its potential as a prognostic indicator in treatments including anti-HER2 agents. METHODS: The analysis...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kochi, Mitsugu, Fujii, Masashi, Masuda, Shinobu, Kanamori, Noriaki, Mihara, Yoshiaki, Funada, Tomoya, Tamegai, Hidenori, Watanabe, Megumu, Suda, Hiroshi, Takayama, Tadatoshi
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2013
Matèries:
Methodology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3937244/
https://ncbi.nlm.nih.gov/pubmed/24261710
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1746-1596-8-191
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars